U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
100591100591Effect of Stopping Risedronate After Long Term Treatment on Bone TurnoverCompletedHas ResultsPostmenopausal Women With OsteoporosisDrug: Risedronate|Drug: Placebo/Risedronatehttps://ClinicalTrials.gov/show/NCT01249261
100592100592PD2i Analysis of Heart Rate Variability in Competitive SportsCompletedNo Results AvailableAutonomic DysfunctionDevice: PD2i Analyzerhttps://ClinicalTrials.gov/show/NCT01249248
100593100593Bandage Contact Lens and Oral Analgesics Versus Patching and Oral Analgesics for Pain Following Pterygium SurgeryRecruitingNo Results AvailablePterygiumProcedure: Patch or bandage contact lenshttps://ClinicalTrials.gov/show/NCT01249235
100594100594Pro-inflammatory Cytokines Profile and Mortality Rate of Critically Ill Septic Patients Following PlasmapheresisRecruitingNo Results AvailableSevere SepsisProcedure: plasmapheresis|Other: plasmapheresishttps://ClinicalTrials.gov/show/NCT01249222
100595100595Outpatient Treatment of Patients With Morbid Obesity - a Two-year Follow upCompletedNo Results AvailableMorbid ObesityDevice: lifestyle advicehttps://ClinicalTrials.gov/show/NCT01249209
100596100596A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: SK-PC-B70Mhttps://ClinicalTrials.gov/show/NCT01249196
100597100597Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldCompletedNo Results AvailableDiphtheria|Tetanus|Pertussis|PoliomyelitisBiological: Concomitant administration|Biological: Separate administrationhttps://ClinicalTrials.gov/show/NCT01249183
100598100598Communication Skills Training and Competency Assessment for Pulmonary and Critical Care Medicine FellowsCompletedNo Results AvailableCommunicationBehavioral: First year program|Other: Control comparisonhttps://ClinicalTrials.gov/show/NCT01249170
100599100599Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the BreastTerminatedNo Results AvailableBreast CancerDevice: Positron Emission Mammography (PEM) and Magnetic Resonance Imaging (MRI)https://ClinicalTrials.gov/show/NCT01249157
100600100600Visual and Refractive Outcomes After Implantation of Aspheric IOLs With Different Dioptric Increments and ManufacturingTerminatedNo Results AvailableCataractDevice: Intraocular Lens (IOL)https://ClinicalTrials.gov/show/NCT01249144
100601100601A Study of Relative Bioavailability and Food Effect Study of GDC-0973 in Healthy SubjectsCompletedNo Results AvailableHealthy VolunteersDrug: GDC-0973/XL518|Drug: GDC-0973/XL518|Drug: GDC-0973/XL518https://ClinicalTrials.gov/show/NCT01249131
100602100602An Absolute Bioavailability Study in Healthy Subjects Comparing Oral to Intravenous Administration of GDC-0973CompletedNo Results AvailableHealthy VolunteersDrug: GDC-0973/XL518https://ClinicalTrials.gov/show/NCT01249118
100603100603MK-2206 for Recurrent Malignant GliomaWithdrawnNo Results AvailableMalignant GliomaDrug: MK-2206https://ClinicalTrials.gov/show/NCT01249105
100604100604Pentoxifylline for Primary Biliary CirrhosisCompletedHas ResultsPrimary Biliary CirrhosisDrug: Pentoxifyllinehttps://ClinicalTrials.gov/show/NCT01249092
100605100605Expanding Rapid Ascertainment Network of Schizophrenia Families in TaiwanRecruitingNo Results AvailableSchizophreniaOther: No intervention would be provided in this researchhttps://ClinicalTrials.gov/show/NCT01249079
100606100606Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung AdenocarcinomaRecruitingNo Results AvailableLung Adenocarcinomahttps://ClinicalTrials.gov/show/NCT01249066
100607100607Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung AdenocarcinomaRecruitingNo Results AvailableLung Adenocarcinomahttps://ClinicalTrials.gov/show/NCT01249053
100608100608The Study of Different Treatment Programs for Patients With Frozen ShoulderRecruitingNo Results AvailableFrozen ShoulderProcedure: Physical therapy|Procedure: steroid intraarticular injectionhttps://ClinicalTrials.gov/show/NCT01249040
100609100609XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyActive, not recruitingNo Results AvailableAngioplasty|Chronic Coronary Occlusion|Stent Thrombosis|Vascular Disease|Myocardial Ischemia|Coronary Artery Stenosis|Coronary Disease|Coronary Artery Disease|Coronary RestenosisDevice: XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)https://ClinicalTrials.gov/show/NCT01249027
100610100610Temperature Study in Cesarean SectionRecruitingNo Results AvailableCesarean Section|HypothermiaDevice: warmed fluids|Device: Fluid warmer and warming blankethttps://ClinicalTrials.gov/show/NCT01249014
100611100611Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in AdolescentsRecruitingNo Results AvailableNausea|Vomiting|ChemotherapyDrug: Oral Aprepitant|Drug: Aprepitanthttps://ClinicalTrials.gov/show/NCT01249001
100612100612Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in KoreaCompletedNo Results AvailableInfections, StreptococcalOther: Synflorixâ„¢ Data collectionhttps://ClinicalTrials.gov/show/NCT01248988
100613100613Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for AsthmaCompletedNo Results AvailableAsthmaDrug: FP/SAL 250/50mcg BID|Drug: GSK2190915 200mg QD (AM)|Drug: GSK2190915 100mg QD (AM)|Drug: Montelukast 10mg QD (PM)|Drug: Placebo tablets (2) (AM)|Drug: Placebo capsule (PM)https://ClinicalTrials.gov/show/NCT01248975
100614100614Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal CancerRecruitingNo Results AvailableOvarian Cancer|Fallopian Tube Cancer|Peritoneal CancerDrug: carboplatin|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT01248962
100615100615A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid TumorsActive, not recruitingNo Results AvailableAdvanced Solid Tumors|Advanced Recurrent Ovarian TumorsDrug: MEDI3617|Drug: MEDI3617 + Bev Q3W Dose Escalation|Drug: MEDI3617 + Bev Q2W Dose Escalation|Drug: Optional Dose Expansion|Drug: MEDI3617 + Weekly Pax Dose Escalation|Drug: MEDI3617 + Pax & Carbo Q3W Dos Esc|Drug: MEDI3617 + Gem & Carbo Q3W Dos Esc|Drug: Advanced Recurrent Ovarian Tumorshttps://ClinicalTrials.gov/show/NCT01248949
100616100616A Study of RO5185426 in Patients With Metastatic MelanomaNo longer availableNo Results AvailableMalignant MelanomaDrug: RO5185426https://ClinicalTrials.gov/show/NCT01248936
100617100617A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaActive, not recruitingNo Results AvailableMultiple Myeloma, Plasma Cell LeukemiaDrug: ARRY-520, KSP(Eg5) inhibitor; intravenous|Drug: Bortezomib, proteasome inhibitor; intravenous or subcutaneous|Drug: Dexamethasone, steroid; oral|Drug: Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous|Drug: ARRY-520, KSP(Eg5) inhibitor; intravenous|Drug: Bortezomib, proteasome inhibitor; intravenous or subcutaneous|Drug: Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneoushttps://ClinicalTrials.gov/show/NCT01248923
100618100618Health Benefits of Alpine Skiing for the ElderlyCompletedNo Results AvailableElderly|Strength|Exercise Capacity|Postural ControlBehavioral: Alpine Skiinghttps://ClinicalTrials.gov/show/NCT01248910
100619100619Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With LapatinibCompletedNo Results AvailableNeoplasms, MetastasisOther: This study is non-interventional study, so this section is not applicable.https://ClinicalTrials.gov/show/NCT01248897
100620100620Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)CompletedHas ResultsTetanus|Poliomyelitis|Hepatitis B|Haemophilus Influenzae Type b|Acellular Pertussis|DiphtheriaBiological: Infanrix hexa™|Biological: Prevenar 13®|Biological: GSK217744https://ClinicalTrials.gov/show/NCT01248884

* Görseller ve İçerik tekif hakkına sahip olabilir